Hylenex (Halozyme Therapeutics) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, & Forecasts, 2020-2025, 2025-2030F, 2035F
Dublin, March 10, 2026 (GLOBE NEWSWIRE) -- The "Hylenex Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's offering.
The historic growth of the hylenex market can be traced to limitations in traditional subcutaneous drug absorption, initial use of animal-derived hyaluronidase, the transition from IV to SC therapy, and the increasing demand for improved rehydration methods and outpatient procedures.
In the forecast period, growth is expected due to the expansion of biologic drug delivery systems, a rising preference for SC therapies, outpatient care, and an upsurge in combination injectable products, particularly within oncology and dermatology. Trends include a shift towards recombinant hyaluronidase, broader application across specialties, and a preference for non-animal-derived enzyme therapies.
The increasing prevalence of skin disorders is a significant growth driver for the hylenex market. With rising incidences of skin conditions due to aging, environmental factors, and an upturn in acne, eczema, and psoriasis cases, hylenex enhances medication absorption, boosting treatment efficacy. For example, the National Library of Medicine reported 101,510 melanoma cases in the EU-27 in 2022, projected to increase to 115,540 by 2040, underscoring the potential market expansion.
Demographic shifts, particularly the growth of the geriatric population, further propel the hylenex market. The population aged 65 and older is growing due to higher life expectancy and medical advances. Hylenex aids in the efficient absorption of medications for those requiring frequent SC injections, reducing complications. As per a WHO report, by 2030, 1 in 6 people worldwide will be 60 or older, highlighting this segment's contribution to market growth.
The aesthetic procedures market boost is another factor driving hylenex market growth. Non-surgical treatments for cosmetic enhancements are in demand, spurred by technological advancements and increased focus on personal appearance. Hylenex is key in correcting or dissolving hyaluronic acid-based fillers, ensuring precise results. The International Society of Aesthetic Plastic Surgery reported over 12.8 million surgical and 17.5 million non-surgical procedures performed globally in recent years, with projections showing a continuous rise, reinforcing hylenex's market potential.
Key players in the hylenex market include Halozyme Therapeutics Inc. Geographically, North America led the market in 2025, while Asia-Pacific is set to be the fastest-growing region. The market covers regions like Asia-Pacific, Europe, North America, South America, the Middle East, and Africa, with key countries including the USA, Canada, Germany, France, UK, Australia, India, China, South Korea, and Japan.
Tariffs have notably impacted costs in the hylenex market, affecting importing recombinant enzyme materials and specialized equipment, particularly in Asia Pacific and Latin America. Despite this, tariffs are also prompting local biomanufacturing investments, bolstering regional supply chains for injectable enzyme therapies.
The hylenex market report delivers comprehensive data on market size, regional shares, major competitors, detailed segments, trends, and growth opportunities, equipping industry participants with an in-depth analysis of current and future market scenarios.
Hylenex, a recombinant human hyaluronidase formulation, enhances absorption and distribution of injectables. It's widely used in subcutaneous drug delivery, rehydration therapy, and aesthetic procedures, lessening allergic reaction risks compared to animal-derived enzymes.
The market comprises hyaluronidase and combination products, serving dermatology, ophthalmology, surgery, fertility, and chemotherapy sectors, with distribution through hospitals, specialty clinics, and retail and online pharmacies. The market value reflects manufacturers' sales to downstream entities or end customers.
Key Technologies & Future Trends
Report Scope:
For more information about this report visit https://www.researchandmarkets.com/r/n6a7bm
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.